This panel discussion may also be found within the video, “Surgical Strategies for Stage IV Stomach Cancer," at [ Ссылка ] , which includes HOPE for Stomach Cancer's entire Inaugural Webinar of its Web Cast Series, with doctors covering a wide range of stomach cancer surgical strategies and topics.

In this discussion:

Yanghee Woo., M.D., Surgical Oncologist at City of Hope Comprehensive Cancer Center in Duarte, California, examines how stomach cancer peritoneal carcinomatosis is adversely affecting adults under the age of 40, and how high the percentage is of Stage IV diagnoses in those young adults. Dr. Woo discusses treatment-resistant tumors in the peritoneum, which are particularly common in the 18-40 age group, and what to do about patients who are not initially surgically curable. Furthermore, she discusses the progress that the medical community has seen in Stage IV Stomach Cancer, as well as how historically poor outcomes are being overcome. Dr. Woo shines a light on the new world of stomach cancer treatment, why some patients don't qualify for clinical trials, and more, with an emphasis on Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Gastric Cancer Peritoneal Carcinomatosis.

Dr. Woo is also the Co-Chair Medical Advisor of HOPE for Stomach Cancer, as well as an Associate Professor of Surgery at the City of Hope Comprehensive Cancer Center.

This panel discussion, as part of HOPE's Inaugural Webinar of its Web Cast Series, “Surgical Strategies for Stage IV Stomach Cancer,” was recorded live on November 7, 2020.

Please click here if you would like to inspire HOPE by making a donation: [ Ссылка ]

Click here if you would like to subscribe to our email list and be notified of future symposiums and events: [ Ссылка ]

свернуть